Metraipolis › archive › dc_243b7a6f36df
Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune-Checkpoint Inhibitors — Europe PMC PMID:42067203
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42067203
- DOI
- 10.1111/1759-7714.70292
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T20:36:53.614Z
- SHA-256 of the archived text
dbc570a03a31fa47649c5c672f4ff1c79b9b5ee5425f59005f3daf00bb6de35f- Stable URL of this page
https://metraipolis.com/documento/dc_243b7a6f36df
How to cite
Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune-Checkpoint Inhibitors — Europe PMC PMID:42067203 — Europe PMC (en), https://europepmc.org/article/MED/42067203 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_243b7a6f36df (Metraipolis archive dc_243b7a6f36df, sha256 dbc570a03a31fa47649c5c672f4ff1c79b9b5ee5425f59005f3daf00bb6de35f)
BibTeX
@misc{dc243b7a6f36df,
title = {Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune-Checkpoint Inhibitors — Europe PMC PMID:42067203},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42067203},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_243b7a6f36df; sha256 dbc570a03a31fa47649c5c672f4ff1c79b9b5ee5425f59005f3daf00bb6de35f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42067203. Agents can read the archived copy with the MCP tool read_document.